fda glp-1 shortage GLP-1s Going Direct, How Novo and Lilly's DTC Strategy is Changing the Game for Patients and Plan Sponsors The FDA says the shortage

pineal-derived short peptide Sequence: Glu-Asp-Arg (EDR) Formula / M.W.: CHNO, ~418.40 g/mol CAS: 175175-23-2 Compound 2: DSIP (Delta Sleep-Inducing Peptide) Class: Endogenous nonapeptide associated with delta-wave sleep induction Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE) Formula / M.W.: CHNO, ~848.81 g/mol CAS: 62568-57-4 Compound 3: Selank Class: Synthetic heptapeptide anxiolytic

10.1074/jbc.M300096200

5 Amino-1-MQ Properties Compound: 5 Amino-1-MQ (5-amino-1-methylquinolinium) Compound Type: Synthetic small molecule Total Content: 50mg Purity: HPLC/MS verified (99%) Form: Lyophilised white/off-white powder Solubility: Reconstitutable with bacteriostatic water Vial Size: 3ml 5 Amino-1-MQ in Bangkok & Thailand Bangkok Peptides supplies 5 Amino-1-MQ locally within Thailand to support research environments requiring consistent, high-quality sourcing

As more people use GLP-1 medications like Ozempic and Rybelsus, questions around fertility, pregnancy, and postpartum planning are becoming more common

Each path trades cost against FDA approval and supply reliability

This reduces the urge to snack or eat large portions, which can be especially helpful when adjusting to new routines after childbirth